VINANTE, Fabrizio
 Distribuzione geografica
Continente #
NA - Nord America 10.529
EU - Europa 9.208
AS - Asia 6.388
SA - Sud America 723
Continente sconosciuto - Info sul continente non disponibili 165
AF - Africa 148
OC - Oceania 15
Totale 27.176
Nazione #
US - Stati Uniti d'America 10.362
RU - Federazione Russa 2.904
SG - Singapore 2.678
GB - Regno Unito 2.535
CN - Cina 2.000
IT - Italia 862
BR - Brasile 566
FR - Francia 559
SE - Svezia 545
DE - Germania 508
VN - Vietnam 471
IE - Irlanda 454
HK - Hong Kong 430
FI - Finlandia 426
KR - Corea 198
UA - Ucraina 164
JP - Giappone 107
CA - Canada 92
IN - India 90
BD - Bangladesh 81
TR - Turchia 70
NG - Nigeria 51
AR - Argentina 50
BE - Belgio 42
ID - Indonesia 41
IQ - Iraq 35
NL - Olanda 35
PL - Polonia 35
MX - Messico 34
ES - Italia 33
IR - Iran 30
PK - Pakistan 29
ZA - Sudafrica 28
EC - Ecuador 23
CO - Colombia 22
UZ - Uzbekistan 20
PH - Filippine 17
AT - Austria 15
CL - Cile 15
CZ - Repubblica Ceca 14
MA - Marocco 13
PY - Paraguay 12
VE - Venezuela 12
AU - Australia 11
LT - Lituania 11
SA - Arabia Saudita 11
BO - Bolivia 10
AE - Emirati Arabi Uniti 8
KZ - Kazakistan 8
PE - Perù 8
RO - Romania 8
CH - Svizzera 7
DZ - Algeria 7
JM - Giamaica 7
MY - Malesia 7
SC - Seychelles 7
SN - Senegal 7
AL - Albania 6
AZ - Azerbaigian 6
BG - Bulgaria 6
CR - Costa Rica 6
IL - Israele 6
JO - Giordania 6
KG - Kirghizistan 6
LV - Lettonia 6
PA - Panama 6
TN - Tunisia 6
CI - Costa d'Avorio 5
EU - Europa 5
KE - Kenya 5
SK - Slovacchia (Repubblica Slovacca) 5
UY - Uruguay 5
EG - Egitto 4
TG - Togo 4
BH - Bahrain 3
BJ - Benin 3
BS - Bahamas 3
DK - Danimarca 3
GT - Guatemala 3
HU - Ungheria 3
LB - Libano 3
NI - Nicaragua 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
PT - Portogallo 3
RS - Serbia 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CM - Camerun 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
Totale 26.984
Città #
Southend 2.242
Singapore 1.518
Jacksonville 1.364
Ashburn 1.153
Chandler 938
Moscow 928
Dallas 869
San Jose 804
Woodbridge 715
Houston 558
Dublin 451
Hong Kong 415
Ann Arbor 390
Verona 308
Council Bluffs 271
Beijing 264
The Dalles 241
Wilmington 203
Lawrence 173
Princeton 173
Shenyang 163
Jinan 162
Nanjing 160
New York 159
Ho Chi Minh City 143
Los Angeles 131
Hanoi 110
Sindelfingen 98
Buffalo 91
Tianjin 91
Hebei 86
Santa Clara 77
Zhengzhou 77
Helsinki 74
Changsha 70
Columbus 70
Boardman 61
Taizhou 58
Munich 57
Nanchang 56
São Paulo 55
Haikou 54
Ningbo 53
Milan 52
Abuja 47
Guangzhou 46
Hangzhou 46
Jiaxing 45
Redondo Beach 44
Orem 40
Brussels 39
San Francisco 37
Tokyo 36
London 35
Turku 35
Lancaster 34
Taiyuan 34
Brooklyn 31
Falls Church 29
Montreal 28
Rome 27
Seattle 27
Frankfurt am Main 26
Warsaw 26
Chennai 24
Chicago 24
Fairfield 24
Norwalk 24
Jakarta 23
Toronto 23
Fuzhou 22
Haiphong 22
Redmond 22
Dong Ket 21
Stockholm 21
Phoenix 20
Lanzhou 19
Lonigo 19
Bologna 18
Da Nang 18
Rio de Janeiro 18
Amsterdam 17
Baghdad 17
Dearborn 17
Denver 17
Düsseldorf 17
Kent 17
Paris 17
Philadelphia 17
Tashkent 17
Washington 17
Brasília 16
Atlanta 15
Shanghai 15
Auburn Hills 14
Ankara 13
Boston 13
Johannesburg 13
Redwood City 13
Seoul 13
Totale 17.555
Nome #
Immunocitologia e immunoistologia delle cellule midollari normali e neoplastiche 447
Preferential release of high amounts of interleukin-8 by myeloid blasts showing monocytic differentiation 439
a (p55) and b (p75) chains of interleukin-2 receptor are expressed by AML blasts 296
Alpha (p55) and beta (p75) chains of the interleukin-2 receptor are expressed by AML blasts 279
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 264
Down-regulation of protein tyrosine phosphatase gamma (PTPRG) in chronic myeloid leukemia (CML) 260
A study of the crosstalk between CD30 and CXCR4 254
Protein Tyrosine Phosphatase Receptor Type γ Is a Functional Tumor Suppressor Gene Specifically Downregulated in Chronic Myeloid Leukemia 247
Increased levels of soluble interleukin-2 receptor in the serum of patients with human immunodeficiency virus infection 242
Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events 240
Endothelin-1 receptor blockade as new possible therapeutic approach in multiple myeloma. 240
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 239
HB-EGF/HER -1 SIGNALLING IN BONE MARROW MESENCHYMAL STEM CELLS: INDUCING CELL EXPANSION AND PREVENTING REVERSIBLY MULTI-LINEAGE DIFFERENTIATION 237
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 234
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 224
Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk 223
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 219
Cellular senescence markers p16INK4 and p21CIP1/WAF are predictors of Hodgkin's lymphoma outcome 216
Bone marrow-, but not thymus-, derived stromal cells inhibit spontaneous apoptosis and induce proliferation in blasts of T-lineage ALL 215
BONE MARROW-DERIVED STROMAL CELLS INHIBIT SPONTANEOUS APOPTOSIS IN NORMAL AND NEOPLASTIC THYMOCYTES 215
CXCL12 and [N33A]CXCL12 in 5637 and HeLa Cells: Regulating HER1 Phosphorylation via Calmodulin/Calcineurin 214
Cellular antigens and soluble molecules and cytokine receptors in leukemia and lymphoma: biological role and clinical applications 210
Expression and role of CD30/CD30L and Fas/FasL in human endothelial cells 208
IL-8 mRNA expression and IL-8 production by acute myeloid leukemia cells 204
Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity 204
Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes 203
Espressione e ruolo funzionale di CD30/CD30L e Fas/FasL in cellule endoteliali umane 202
Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission 202
Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease 199
Bone marrow mesenchymal stem cells express HER-1 and are sensitive to the effect of HB-EGF 199
Comparative analysis of normal versus CLL B-lymphocytes reveals patient-specific variability in signaling mechanisms controlling LFA-1 activation by chemokines 199
Hairy cell leukemia in kidney transplantation: lesson from a rare disorder. 199
Activation of Protein Tyrosine Phosphatase Receptor Type γ Suppresses Mechanisms of Adhesion and Survival in Chronic Lymphocytic Leukemia Cells 197
In reply to Schäfer et al: new evidence on the role of endothelin-1 axis as a potential therapeutic target in multiple myeloma 196
Biological prognostic factors in indolent lymphoma 195
CXCR4- and BCR-triggered integrin activation in B-cell chronic lymphocytic leukemia cells depends on JAK2-activated Bruton's tyrosine kinase 195
BID and the α-bisabolol-triggered cell death program: converging on mitochondria and lysosomes 194
Monoterapia empirica con ceftazidime nelle infezioni di pazienti neutropenici affetti da emopatie maligne 192
Highly concentrated urine-purified Tac peptide fails to inhibit IL-2-dependent cell proliferation in vitro 192
Morphological and Functional Changes in the Peritumoral Adipose Tissue of Colorectal Cancer Patients 192
Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome 190
HUMAN T-LYMPHOBLASTIC LEUKAEMIA CELLS PRODUCE IL-8 IN RESPONSE TOCXCL12 SECRETED BY NORMAL BONE MARROW STROMA 190
Soluble interleukin-2 receptor in the serum of patients with Hodgkin's Disease: A new biological marker of disease activity 189
α-bisabolol is an effective proapoptotic agent against BCR-ABL+ cells in synergism with Imatinib and Nilotinib 189
Leucemie 186
AML blasts express heparin-binding epidermal growth factor-like growth factor (HB-EGF)/diphtheria toxin receptor 186
Assetto citochinico e pattern del CD30 durante la maturazione del sistema immunitario 185
Bone marrow-derived stromal cells inhibit spontaneous apoptosis and induce proliferation in blasts of T acute lymphoblastic leukaemia: the role of interleukin 7 185
The Sesquiterpene Oil {alpha}-Bisabolol Induces Apoptosis of B-Chronic Lymphocytic Leukemia Primary Cells 185
JAK2 tyrosine kinase mediates integrin activation induced by CXCL12 in B-cell chronic lymphocytic leukemia 184
A single amino acid substitution in CXCL12 confers functional selectivity at the beta-arrestin level 184
High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemia 181
CD30 triggering by agonistic antibodies regulates CXCR4 expression and CXCL12 chemotactic activity in the cell line L540. 179
Correlation between clinical features and circulating levels of soluble intercellular adhesion molecule-1 in Hodgkin's disease 178
Efficient lysis of B-chronic lymphocytic leukemia cells by the plant-derived sesquiterpene alcohol α-bisabolol, a dual proapoptotic and antiautophagic agent 177
I marcatori delle cellule linfoidi 176
Studio immunologico delle popolazioni linfoidi normali nella leucemia acuta mieloide in remissione completa. Evidenze di un possibile controllo immunologico della ricaduta 174
Soluble forms of p55-IL-2R alpha, CD8, and CD30 molecules as markers of lymphoid cell activation in infectious mononucleosis 173
Pro-apoptotic activity of α-bisabolol in preclinical models of primary human acute leukemia cells 172
Thymic epithelial cell-derived interleukin-7 promotes survival of human T-cell acute lymphoblastic leukemia 172
L'alfa interferone nei pazienti con Hairy Cell Leukemia attiva il sistema NK, ma non induce un'attività citotossica specifica verso le cellule hairy 171
CD30+ L540 cells express CCR5 and CXCR4 molecules, CCR3 mRNA and release RANTES and MIP-1alfa 171
Interleukin 7 requirement for survival of T-cell acute lymphoblastic leukemia and human thymocytes on bone marrow stroma. 168
Decreased apoptotic priming and loss of BCL-2 dependence are functional hallmarks of Richter's syndrome 167
Increased levels of soluble CD8 molecule in the serum of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related disorders 167
Immunophenotypic approach to the detection of minimal residual disease in acute leukemia 167
Immunologic abnormalities in angioimmunoblastic lymphadenopathy 165
Classical Hodgkin lymphoma cells may promote an IL-17-enriched microenvironment 163
HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation 161
Mitochondrial-Mediated Apoptosis by the Sesquiterpene Oil {alpha}-Bisabolol and Its Synergism with Imatinib and Nilotinib In BCR-ABL+ Cells. 161
Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission 159
Role for IFN-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. 159
Gram-negative septicemia in patients with hematologic malignancies 157
Immunologic evidence of a strong association between non-Hodgkin lymphoma and simian virus 40 157
Soluble interleukin-2 receptor in hairy cell leukemia: A reliable marker of disease 155
Sesquiterpene α-bisabolol, which binds to Bid in lipid rafts, induces apoptosis in BCR/ABL+ cell lines through membrane depolarization. 155
Monocyte-to-macrophage switch reversibly impaired by Ibrutinib. 155
Immunohistochemical and flow cytometric analysis of the expression of cyclin-dependent kinase 6 (CDK6, PLSTIRE) in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia 151
Bone marrow stromal cells up-regulate interleukin 8 production in human T-lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-κB and JNK/AP-1 pathways 150
Increased serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and rheumatoid arthritis 149
Increased serum levels of soluble IL-2 receptor, CD30 and CD8 molecules, and gamma-interferon in angioimmunoblastic lymphadenopathy: possible pathogenetic role of immunoactivation mechanisms 148
Anemie 146
Differential expression of cyclin-dependent kinase 6 (CDK6, PLSTIRE) in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia. 145
Role of CD30 molecule in HIV-1 infection 142
Le molecole solubili in oncoematologia 142
Granulocyte-macrophage colony-stimulating factor induces expression of heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor and sensitivity to diphtheria toxin in human neutrophils 142
Antibodies binding granulocyte-macrophage colony stimulating factor produced by cord blood-derived B cell lines immortalized by Epstein-Barr virus in vitro 142
Circulating levels of soluble CD23 reflect clinical and biological features of leukemic B-cell chronic lymphoproliferative disorders 141
CD30 antigen and cellular biology of Reed-Sternberg cells [letter; comment] 140
Trisomy 8 in myelodysplasia and acute leukemia is constitutional in 15-20% of cases 140
Soluble molecules as biological markers in Hodgkin's disease 139
Immunohistochemical demonstration of follicular dendritic cells in bone marrow involvement of B-cell chronic lymphocytic leukemia. 138
High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS 137
CD30 e assetto citochinico dei linfociti T, valutato mediante analisi citofluorimetrica, in un caso di sindrome da iper-IgE asintomatica 137
High serum levels of soluble interleukin-2 receptors in sarcoidosis 137
The CD4 molecule belongs to the phenotypic repertoire of most cases of acute myeloid leukemia 137
Il recettore per l'interleuchina-2 sulle cellule normali e neoplastiche 137
Functional analysis of cytotoxic cells in patients with acute nonlymphoblastic leukemia in complete remission 136
L'immunofenotipo nelle leucemie 135
ICAM-1 tissue overexpression associated with increased serum levels of its soluble form in Hodgkin's disease 134
Totale 18.864
Categoria #
all - tutte 84.920
article - articoli 57.576
book - libri 0
conference - conferenze 24.043
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.301
Totale 169.840


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022994 0 0 13 92 109 48 37 77 51 80 170 317
2022/20232.836 229 247 254 539 243 716 14 165 311 27 58 33
2023/20241.573 66 113 162 152 173 209 105 292 10 26 159 106
2024/20253.426 216 248 106 577 167 98 131 141 505 191 278 768
2025/20269.250 724 730 600 1.409 2.229 692 992 510 611 510 105 138
2026/2027468 91 251 126 0 0 0 0 0 0 0 0 0
Totale 27.176